Your Health, We Care
Release date: 2026-04-17 15:31:07 Recommended: 10
Selinexor may cause serious or even life-threatening side effects. Patients and their families must be fully informed and remain vigilant. The most common and serious side effects include decreased platelet count and decreased white blood cell count. Thrombocytopenia (low platelets) may increase the risk of bleeding, which can be fatal in severe cases; leukopenia (low white blood cells) increases the risk of infection. During treatment, if any unusual bleeding, easy bruising, fever, chills, cough, shortness of breath, pain on urination, or general malaise occurs, the medical team must be notified immediately. In addition, Selinexor may cause neurological side effects, manifesting as dizziness, fainting, decreased alertness, altered mental status, or even hallucinations. Patients experiencing these symptoms should not drive or operate hazardous machinery and should seek immediate medical attention.
In addition to the serious side effects listed above, Selinexor may cause nausea, vomiting, and/or diarrhea. These gastrointestinal reactions can sometimes be severe and may lead to a risk of dehydration. The medical team will typically prescribe antiemetics or antidiarrheal medications in advance to help manage these symptoms. Loss of appetite and weight loss are also very common; patients should proactively report their eating status and weight changes to their doctor. Low blood sodium levels are another common but potentially serious issue, and the doctor may recommend dietary adjustments or intravenous fluids. Furthermore, Selinexor may cause new cataracts or worsen existing cataracts, presenting as double vision, blurred vision, light sensitivity, or glare. Patients should immediately inform their doctor if they experience any of these eye symptoms, as surgical intervention may be necessary.
Although the list of side effects of Selinexor may seem concerning, it is important to recognize that these side effects are generally manageable and/or reversible with appropriate medical care. Clinical trial data show that more than 60% of patients receiving Selinexor required dose adjustments during treatment, and the regimen remained effective after such adjustments. The dose can be reduced multiple times before discontinuing Selinexor. Regarding nausea, the most common side effect, clinical studies have shown that among adult patients who experienced nausea within the first month of taking Selinexor, nine out of ten had their symptoms improve or resolve completely. Patients should proactively communicate any discomfort to their medical team. The more information the medical team has, the better they can help optimize the treatment experience, including adjusting the dose and using supportive medications.
